This website uses cookies to ensure you get the best experience on our website.
Read more
News
-
March 20, 2024
World Precision Instruments (WPI) is pleased to announce their strategic partnership with TotalLab, paving the way for the integration of 21 CFR Part 11 compliance into its esteemed EVOM family of products...more
-
November 10, 2023
SARASOTA, Fla., November 10, 2023 /PRNewswire/ -- World Precision Instruments (WPI), a leading provider of high-quality laboratory instruments and equipment for basic research and drug development, is proud to announce the establishment of its Scientific Advisory Board (SAB). Comprised of renowned experts in various scientific disciplines, the SAB will play a crucial role in guiding and advancing WPI's commitment to innovation and excellence in scientific research...more
-
October 24, 2023
SARASOTA, Fla., October 23, 2023 /PRNewswire/ -- World Precision Instruments (WPI) is excited to expand the capability of the EVOM™ Auto, now offering both 24 and 96 multiwell capacity in one single platform. The EVOM™ Auto enables rapid and reproducible measurements of Transepithelial Electrical Resistance (TEER), a well-established, non-invasive and widely accepted method of evaluating epithelial and endothelial cells and tissues. ...more
-
October 06, 2023
The foundation of many research laboratories is the ability to do in vitro studies, which rely on the ability to culture cells in the laboratory. Cell culture technologies have advanced significantly, allowing researchers to successfully culture many types of cell lines...more
-
September 01, 2023
WPI was recently featured in Aviation Week as a supplier of stainless steel mesh baskets for manufacturing and electronics...more
-
August 17, 2023
On December 29, 2022, the FDA Modernization Act 2.0 was signed into law, which allows alternatives to animal testing for new drug development. This has opened the door for new pathways to drug discovery and development that involve Artificial Intelligence, cell culture-based assays, and organ-on-chip applications. It also moved the field closer to the three Rs of animal testing:...more
-
June 27, 2023
In 2022, the United States Food and Drug Administration (FDA) approved 37 new drugs, of which 20 were chemical entities and 17 were biologics. In 2023, drug discovery remains strong with many new advancements a result of changing landscapes in both the types of drugs that are being developed and the new and innovative assay that are being launched to evaluate drugs preclinically. Therapeutic development is still highly focused on diseases that affect large populations of people for which there are lack of effective treatments, with 2023’s most anticipated drug launches expected to be in areas of cancer, Alzheimer’s disease, cardiovascular disease, and ulcerative colitis...more
-
April 13, 2023World Precision Instruments (WPI) is excited to launch the newest member to its EVOM™ family of products, the EVOM™ Auto. The new EVOM™ Auto enables rapid and reproducible measurements of Transepithelial Electrical Resistance (TEER), a well-established and widely accepted method of evaluating epithelial and endothelial cells and tissues, in vitro. WPI’s EVOM™ Auto combines TEER technology with high throughput screening capabilities, resulting in the automated measurement of resistance in 96-well cell culture plates. This data gives scientists and drug discovery laboratories insights into tissue and monolayer barrier integrity, cell permeability, cell confluency, and can readout the critical physiology of barrier tissues such as the blood-brain barrier, the gastrointestinal tract, the lung, and the skin. ...more
-
January 25, 2023
The US FDA Modernization Act 2.0 replaces the 1938 Federal Food, Drug and Cosmetic Act which required animal testing prior to human trials. The new law, sponsored in the Senate by Rand Paul and co-sponsored by 11 other bi-partisan senators, eliminates that requirement. Representatives Vern Buchanan and Elaine Luria introduced the companion bill in the House, with over 105 bi-partisan cosponsors. President Biden signed the bill into law in December 2022. With the advent of modern research methods, we now have many options available to test the efficacy and safety of new pharmaceuticals without requiring the use of animals. Some of these methods include cell-based assays, microphysiological systems like organ-on-a chip (OOC), and bio-printed or computer models. In 2019, the cost of bringing a new drug to market varied greatly from $161...more
-
September 13, 2022WPI is very excited to announce our newest product launch and collaboration with MatTek Life Sciences. The companies will offer both MatTek PermaCell Cell Culture Insert Plates and compatible customized World Precision Instruments’ STX HTS EVOM™ Electrode for TEER to their respective customers, available immediately to the life sciences market...more
-
January 03, 2019
The Butantan Institute, an agency linked to the State Department of Health of São Paulo and one of the largest biomedical research centers in the world, held the 4th edition of the Zebrafish Creation and Management university extension course in December where they exhibited WPI's Zebrafish Microinjection System.
The training is aimed at professionals and post-graduate students involved in zebrafish research as an animal model. The program addressed the physical characteristics, the environment of origin and the way of reproduction and growth of this fish. The coordinators are the researchers Mônica Lopes Ferreira and Carla Lima, responsible for the Zebrafish Platform of CeTICS Butantan whose current capacity holds 6,000 adult fish.
https://www.redezebrafish.com.br/parceiros
...more -
October 08, 2018
Jonas de Jesus, from WPI Brasil visit the winner of a contest to name a mascot for the Zebrafish Network. Jonas presented the winner with a surgical kit for zebrafish research.
The project "The Zebrafish Network" is a result of the partnership of the Center for Toxins, Immune Response and Cell Signaling (CeTICS) of the Butantan Institute, and aims to promote communication and integration, as well as foster collaborations between researchers studying the fish "Paulistinha ", Which has been used for many scientific studies because of its genetic similarity with humans (70%).
"The idea is that everyone who belongs to the network can divulge their work, interact with other researchers and inform about what is happening, such as publication of articles, lectures and congresses on the subject," explains Mônica Lopes , director of the Special Laboratory of Toxicology and coordinator of the Zebrafish Platform.
Since the Zebrafish Platform opened in the IB in 2015, a network...more
-
April 14, 2017
World Precision Instruments was selected to receive the FVMA (Florida Veterinary Medical Association) Industry Award for 2017....more
-
October 07, 2008
Contact: Kendra Newman FOR IMMEDIATE RELEASE Tel: (941) 371-1003 E-mail: [email protected] WPI Sensors are out of this world WPI sensors have been selected for use in the space shuttle by the European Space Agency. After six